Endra life sciences regains compliance with nasdaq minimum bid price requirement

Ann arbor, mich.--(business wire)--endra life sciences inc. (nasdaq: ndra), an innovator of thermo acoustic enhanced ultrasound (taeus®), today announced that it has regained compliance with the minimum bid price requirement set forth by the nasdaq stock market llc (“nasdaq”). on november 21, 2024, the company received notification from the nasdaq listing qualifications department confirming its compliance with listing rule 5550(a)(2), thereby meeting nasdaq's maintenance requirements for listi.
NDAQ Ratings Summary
NDAQ Quant Ranking